Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan Conditioning in MDS
NCT01062490Phase 2Completed
- Sponsor
- medac GmbH
- Start
- Nov 2004
- Primary completion
- Jul 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of treosulfan in myelodysplastic syndrome (MDS), sponsored by medac GmbH. Started Nov 2004; status: completed.
02
Drugs
treosulfan
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01062490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01062490.